BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32089454)

  • 1. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
    Kim KN; Qureshi MM; Huang D; Ko NY; Cassidy M; Oshry L; Hirsch AE
    Clin Breast Cancer; 2020 Apr; 20(2):e200-e213. PubMed ID: 32089454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
    Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
    Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk NZ; Utkan Z; Evrensel T; Sezgin E;
    J Am Coll Surg; 2021 Dec; 233(6):742-751.e5. PubMed ID: 34530124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
    Gultekin M; Yazici O; Eren G; Yuce D; Aksoy S; Ozisik Y; Guler N; Yazici G; Hurmuz P; Yildiz F; Altundag K; Gurkaynak M
    Breast; 2014 Dec; 23(6):775-83. PubMed ID: 25201554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
    Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.
    Reinhorn D; Mutai R; Yerushalmi R; Moore A; Amir E; Goldvaser H
    Breast; 2021 Aug; 58():173-181. PubMed ID: 34158167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
    Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Mazouni C; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; de La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Robain M; Filleron T; Cailliot C; Dalenc F
    Ann Surg Oncol; 2019 Feb; 26(2):356-365. PubMed ID: 30539492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
    Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
    J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
    Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
    Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Radiotherapy and Histological Risk Factors on Outcomes in Malignant Phyllodes Tumors.
    Wong RX; Koh YS; Wong FY; Kusumawidjaja G; Ng WL; Yeo RMC; Farid M; Sheng Chan JY; Yan Z; Gudi MA; Tan PH
    Clin Breast Cancer; 2020 Dec; 20(6):e695-e700. PubMed ID: 32636151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.
    Buszek SM; Lin HY; Bedrosian I; Tamirisa N; Babiera GV; Shen Y; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):795-802. PubMed ID: 31377160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy.
    Cao L; Cai G; Xu F; Yang ZZ; Yu XL; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
    Medicine (Baltimore); 2016 Aug; 95(32):e4230. PubMed ID: 27512838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.
    Mehdi M; Kong AL; Frebault J; Huang S; Huang CC; Cortina CS
    J Surg Res; 2021 Aug; 264():138-148. PubMed ID: 33823490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
    Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk Z; Utkan Z; Ozaslan C; Evrensel T; Uras C; Aksaz E; Soyder A; Ugurlu U; Col C; Cabioglu N; Bozkurt B; Uzunkoy A; Koksal N; Gulluoglu BM; Unal B; Atalay C; Yıldırım E; Erdem E; Salimoglu S; Sezer A; Koyuncu A; Gurleyik G; Alagol H; Ulufi N; Berberoglu U; Dulger M; Cengiz O; Sezgin E; Johnson R
    Ann Surg Oncol; 2018 Oct; 25(11):3141-3149. PubMed ID: 29777404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
    Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
    Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast.
    Kennedy WR; Gabani P; Acharya S; Thomas MA; Zoberi I
    Cancer Med; 2019 Apr; 8(4):1379-1388. PubMed ID: 30864198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
    Fayanju OM; Ren Y; Suneja G; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):377-389. PubMed ID: 31678225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.